There is a vast number of ADCs that never make it to the clinic let alone to market, and this is largely due to toxicological challenges providing a narrow therapeutic […]

With the exciting news that Novartis has received US FDA approval for Pluvicto for previously-treated patients with PSMA-positive metastatic castration-resistant prostate cancer, the TRP space is continuing to go from strength to strength. This is why the upcoming 2nd […]

Design & Engineer Functional & Manufacturable Novel Fusion Proteins Prepare to be captivated by the Fusion Protein Engineering & Developability Summit, the ultimate event tailored to drug developers with groundbreaking […]

Established industry leaders and emerging innovators such as Adicet Bio, IN8Bio, Sanofi, Merck, LAVA Therapeutics, Takeda and Leucid Bio are driving the race to demonstrate the potential of Gamma Delta […]